Gift 5 articles to anyone you choose each month when you subscribe. Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...
American pharmaceutical giant Eli Lilly is the maker of weight-loss drug Mounjaro ... the PBS mid-next year, people briefed on the plans but not authorised to speak publicly told The Australian ...
Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...
Musk elaborated in a follow-up post he is technically using the Eli Lilly weight-loss drug Mounjaro over Novo Nordisk’s Ozempic, “but that doesn’t have the same ring to it.” The post comes ...
Without it, PBS deferrals behind closed doors will simply become the norm.” James Dowling is a reporter in The Australian’s Sydney bureau. As an intern at The Age he was nominated for a Quill ...
Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity medication, Tirzepatide—commercially known as Mounjaro—in India by 2025.
Mounjaro is a GLP-1 inhibitor developed to help people with diabetes regulate their blood glucose. Elon Musk, the 53-year-old CEO of Tesla and SpaceX, recently shared a festive image of himself ...
Hundreds of Australians with breast and prostate cancer will benefit from new treatments being added to the Pharmaceutical Benefits Scheme. Crowe lashes 'conspiracy theories' after Souths rumours ...
Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this year, but many eligible patients will have to wait.
Elon Musk has revealed that he uses Mounjaro, after previously showing his support for similar weight-loss drugs. In an X post, a lean-looking Musk shared a photo of himself wearing a Santa Claus ...
From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...
Over the last year, weight loss jabs have become highly popular, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also ...